GO Annotation
| Category | Term ID | Term description |
|---|---|---|
| Process | GO:0000003 | Reproduction |
| Process | GO:0000122 | Negative regulation of transcription by RNA polymerase II |
| Process | GO:0001503 | Ossification |
| Process | GO:0001649 | Osteoblast differentiation |
| Process | GO:0001654 | Eye development |
| Process | GO:0001704 | Formation of primary germ layer |
| Process | GO:0001706 | Endoderm formation |
| Process | GO:0001708 | Cell fate specification |
| Process | GO:0001711 | Endodermal cell fate commitment |
| Process | GO:0001714 | Endodermal cell fate specification |
| Process | GO:0001763 | Morphogenesis of a branching structure |
| Process | GO:0002009 | Morphogenesis of an epithelium |
| Process | GO:0002052 | Positive regulation of neuroblast proliferation |
| Process | GO:0002088 | Lens development in camera-type eye |
| Process | GO:0002089 | Lens morphogenesis in camera-type eye |
| Process | GO:0003006 | Developmental process involved in reproduction |
| Process | GO:0003008 | System process |
| Process | GO:0006355 | Regulation of transcription, DNA-templated |
| Process | GO:0006357 | Regulation of transcription by RNA polymerase II |
| Process | GO:0006950 | Response to stress |
| Process | GO:0007275 | Multicellular organism development |
| Process | GO:0007369 | Gastrulation |
| Process | GO:0007399 | Nervous system development |
| Process | GO:0007417 | Central nervous system development |
| Process | GO:0007420 | Brain development |
| Process | GO:0007423 | Sensory organ development |
| Process | GO:0007492 | Endoderm development |
| Process | GO:0007548 | Sex differentiation |
| Process | GO:0007600 | Sensory perception |
| Process | GO:0007605 | Sensory perception of sound |
| Process | GO:0008152 | Metabolic process |
| Process | GO:0008284 | Positive regulation of cell population proliferation |
| Process | GO:0008285 | Negative regulation of cell population proliferation |
| Process | GO:0008593 | Regulation of Notch signaling pathway |
| Process | GO:0009581 | Detection of external stimulus |
| Process | GO:0009582 | Detection of abiotic stimulus |
| Process | GO:0009605 | Response to external stimulus |
| Process | GO:0009611 | Response to wounding |
| Process | GO:0009612 | Response to mechanical stimulus |
| Process | GO:0009628 | Response to abiotic stimulus |
| Process | GO:0009653 | Anatomical structure morphogenesis |
| Process | GO:0009790 | Embryo development |
| Process | GO:0009887 | Animal organ morphogenesis |
| Process | GO:0009888 | Tissue development |
| Process | GO:0009889 | Regulation of biosynthetic process |
| Process | GO:0009890 | Negative regulation of biosynthetic process |
| Process | GO:0009891 | Positive regulation of biosynthetic process |
| Process | GO:0009892 | Negative regulation of metabolic process |
| Process | GO:0009893 | Positive regulation of metabolic process |
| Process | GO:0009966 | Regulation of signal transduction |
| Process | GO:0009967 | Positive regulation of signal transduction |
| Process | GO:0009968 | Negative regulation of signal transduction |
| Process | GO:0009987 | Cellular process |
| Process | GO:0010033 | Response to organic substance |
| Process | GO:0010035 | Response to inorganic substance |
| Process | GO:0010038 | Response to metal ion |
| Process | GO:0010467 | Gene expression |
| Process | GO:0010468 | Regulation of gene expression |
| Process | GO:0010556 | Regulation of macromolecule biosynthetic process |
| Process | GO:0010557 | Positive regulation of macromolecule biosynthetic process |
| Process | GO:0010558 | Negative regulation of macromolecule biosynthetic process |
| Process | GO:0010564 | Regulation of cell cycle process |
| Process | GO:0010604 | Positive regulation of macromolecule metabolic process |
| Process | GO:0010605 | Negative regulation of macromolecule metabolic process |
| Process | GO:0010646 | Regulation of cell communication |
| Process | GO:0010647 | Positive regulation of cell communication |
| Process | GO:0010648 | Negative regulation of cell communication |
| Process | GO:0010720 | Positive regulation of cell development |
| Process | GO:0010948 | Negative regulation of cell cycle process |
| Process | GO:0019219 | Regulation of nucleobase-containing compound metabolic process |
| Process | GO:0019222 | Regulation of metabolic process |
| Process | GO:0019827 | Stem cell population maintenance |
| Process | GO:0021536 | Diencephalon development |
| Process | GO:0021537 | Telencephalon development |
| Process | GO:0021543 | Pallium development |
| Process | GO:0021872 | Forebrain generation of neurons |
| Process | GO:0021879 | Forebrain neuron differentiation |
| Process | GO:0021953 | Central nervous system neuron differentiation |
| Process | GO:0021983 | Pituitary gland development |
| Process | GO:0021984 | Adenohypophysis development |
| Process | GO:0021987 | Cerebral cortex development |
| Process | GO:0022008 | Neurogenesis |
| Process | GO:0022407 | Regulation of cell-cell adhesion |
| Process | GO:0022409 | Positive regulation of cell-cell adhesion |
| Process | GO:0022414 | Reproductive process |
| Process | GO:0023051 | Regulation of signaling |
| Process | GO:0023056 | Positive regulation of signaling |
| Process | GO:0023057 | Negative regulation of signaling |
| Process | GO:0030111 | Regulation of Wnt signaling pathway |
| Process | GO:0030154 | Cell differentiation |
| Process | GO:0030155 | Regulation of cell adhesion |
| Process | GO:0030162 | Regulation of proteolysis |
| Process | GO:0030178 | Negative regulation of Wnt signaling pathway |
| Process | GO:0030182 | Neuron differentiation |
| Process | GO:0030323 | Respiratory tube development |
| Process | GO:0030324 | Lung development |
| Process | GO:0030539 | Male genitalia development |
| Process | GO:0030856 | Regulation of epithelial cell differentiation |
| Process | GO:0030858 | Positive regulation of epithelial cell differentiation |
| Process | GO:0030900 | Forebrain development |
| Process | GO:0030910 | Olfactory placode formation |
| Process | GO:0031099 | Regeneration |
| Process | GO:0031128 | Developmental induction |
| Process | GO:0031323 | Regulation of cellular metabolic process |
| Process | GO:0031324 | Negative regulation of cellular metabolic process |
| Process | GO:0031325 | Positive regulation of cellular metabolic process |
| Process | GO:0031326 | Regulation of cellular biosynthetic process |
| Process | GO:0031327 | Negative regulation of cellular biosynthetic process |
| Process | GO:0031328 | Positive regulation of cellular biosynthetic process |
| Process | GO:0032501 | Multicellular organismal process |
| Process | GO:0032502 | Developmental process |
| Process | GO:0032526 | Response to retinoic acid |
| Process | GO:0033993 | Response to lipid |
| Process | GO:0035019 | Somatic stem cell population maintenance |
| Process | GO:0035239 | Tube morphogenesis |
| Process | GO:0035270 | Endocrine system development |
| Process | GO:0035295 | Tube development |
| Process | GO:0035987 | Endodermal cell differentiation |
| Process | GO:0040007 | Growth |
| Process | GO:0042127 | Regulation of cell population proliferation |
| Process | GO:0042221 | Response to chemical |
| Process | GO:0042246 | Tissue regeneration |
| Process | GO:0042440 | Pigment metabolic process |
| Process | GO:0042471 | Ear morphogenesis |
| Process | GO:0042472 | Inner ear morphogenesis |
| Process | GO:0043010 | Camera-type eye development |
| Process | GO:0043170 | Macromolecule metabolic process |
| Process | GO:0043281 | Regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| Process | GO:0043408 | Regulation of MAPK cascade |
| Process | GO:0043410 | Positive regulation of MAPK cascade |
| Process | GO:0043583 | Ear development |
| Process | GO:0043584 | Nose development |
| Process | GO:0043586 | Tongue development |
| Process | GO:0045165 | Cell fate commitment |
| Process | GO:0045595 | Regulation of cell differentiation |
| Process | GO:0045596 | Negative regulation of cell differentiation |
| Process | GO:0045597 | Positive regulation of cell differentiation |
| Process | GO:0045664 | Regulation of neuron differentiation |
| Process | GO:0045665 | Negative regulation of neuron differentiation |
| Process | GO:0045666 | Positive regulation of neuron differentiation |
| Process | GO:0045667 | Regulation of osteoblast differentiation |
| Process | GO:0045668 | Negative regulation of osteoblast differentiation |
| Process | GO:0045747 | Positive regulation of Notch signaling pathway |
| Process | GO:0045785 | Positive regulation of cell adhesion |
| Process | GO:0045786 | Negative regulation of cell cycle |
| Process | GO:0045892 | Negative regulation of transcription, DNA-templated |
| Process | GO:0045893 | Positive regulation of transcription, DNA-templated |
| Process | GO:0045934 | Negative regulation of nucleobase-containing compound metabolic process |
| Process | GO:0045935 | Positive regulation of nucleobase-containing compound metabolic process |
| Process | GO:0045944 | Positive regulation of transcription by RNA polymerase II |
| Process | GO:0046148 | Pigment biosynthetic process |
| Process | GO:0046661 | Male sex differentiation |
| Process | GO:0046686 | Response to cadmium ion |
| Process | GO:0048286 | Lung alveolus development |
| Process | GO:0048513 | Animal organ development |
| Process | GO:0048518 | Positive regulation of biological process |
| Process | GO:0048519 | Negative regulation of biological process |
| Process | GO:0048522 | Positive regulation of cellular process |
| Process | GO:0048523 | Negative regulation of cellular process |
| Process | GO:0048562 | Embryonic organ morphogenesis |
| Process | GO:0048568 | Embryonic organ development |
| Process | GO:0048583 | Regulation of response to stimulus |
| Process | GO:0048584 | Positive regulation of response to stimulus |
| Process | GO:0048585 | Negative regulation of response to stimulus |
| Process | GO:0048589 | Developmental growth |
| Process | GO:0048592 | Eye morphogenesis |
| Process | GO:0048593 | Camera-type eye morphogenesis |
| Process | GO:0048598 | Embryonic morphogenesis |
| Process | GO:0048608 | Reproductive structure development |
| Process | GO:0048646 | Anatomical structure formation involved in morphogenesis |
| Process | GO:0048663 | Neuron fate commitment |
| Process | GO:0048699 | Generation of neurons |
| Process | GO:0048729 | Tissue morphogenesis |
| Process | GO:0048731 | System development |
| Process | GO:0048732 | Gland development |
| Process | GO:0048754 | Branching morphogenesis of an epithelial tube |
| Process | GO:0048806 | Genitalia development |
| Process | GO:0048839 | Inner ear development |
| Process | GO:0048852 | Diencephalon morphogenesis |
| Process | GO:0048853 | Forebrain morphogenesis |
| Process | GO:0048854 | Brain morphogenesis |
| Process | GO:0048856 | Anatomical structure development |
| Process | GO:0048863 | Stem cell differentiation |
| Process | GO:0048869 | Cellular developmental process |
| Process | GO:0048880 | Sensory system development |
| Process | GO:0050678 | Regulation of epithelial cell proliferation |
| Process | GO:0050680 | Negative regulation of epithelial cell proliferation |
| Process | GO:0050767 | Regulation of neurogenesis |
| Process | GO:0050769 | Positive regulation of neurogenesis |
| Process | GO:0050789 | Regulation of biological process |
| Process | GO:0050790 | Regulation of catalytic activity |
| Process | GO:0050793 | Regulation of developmental process |
| Process | GO:0050794 | Regulation of cellular process |
| Process | GO:0050877 | Nervous system process |
| Process | GO:0050885 | Neuromuscular process controlling balance |
| Process | GO:0050896 | Response to stimulus |
| Process | GO:0050905 | Neuromuscular process |
| Process | GO:0050906 | Detection of stimulus involved in sensory perception |
| Process | GO:0050910 | Detection of mechanical stimulus involved in sensory perception of sound |
| Process | GO:0050954 | Sensory perception of mechanical stimulus |
| Process | GO:0050957 | Equilibrioception |
| Process | GO:0050973 | Detection of mechanical stimulus involved in equilibrioception |
| Process | GO:0050974 | Detection of mechanical stimulus involved in sensory perception |
| Process | GO:0050982 | Detection of mechanical stimulus |
| Process | GO:0051093 | Negative regulation of developmental process |
| Process | GO:0051094 | Positive regulation of developmental process |
| Process | GO:0051171 | Regulation of nitrogen compound metabolic process |
| Process | GO:0051172 | Negative regulation of nitrogen compound metabolic process |
| Process | GO:0051173 | Positive regulation of nitrogen compound metabolic process |
| Process | GO:0051239 | Regulation of multicellular organismal process |
| Process | GO:0051240 | Positive regulation of multicellular organismal process |
| Process | GO:0051246 | Regulation of protein metabolic process |
| Process | GO:0051252 | Regulation of RNA metabolic process |
| Process | GO:0051253 | Negative regulation of RNA metabolic process |
| Process | GO:0051254 | Positive regulation of RNA metabolic process |
| Process | GO:0051336 | Regulation of hydrolase activity |
| Process | GO:0051606 | Detection of stimulus |
| Process | GO:0051716 | Cellular response to stimulus |
| Process | GO:0051726 | Regulation of cell cycle |
| Process | GO:0051960 | Regulation of nervous system development |
| Process | GO:0051962 | Positive regulation of nervous system development |
| Process | GO:0052547 | Regulation of peptidase activity |
| Process | GO:0052548 | Regulation of endopeptidase activity |
| Process | GO:0060041 | Retina development in camera-type eye |
| Process | GO:0060042 | Retina morphogenesis in camera-type eye |
| Process | GO:0060235 | Lens induction in camera-type eye |
| Process | GO:0060255 | Regulation of macromolecule metabolic process |
| Process | GO:0060284 | Regulation of cell development |
| Process | GO:0060322 | Head development |
| Process | GO:0060425 | Lung morphogenesis |
| Process | GO:0060429 | Epithelium development |
| Process | GO:0060441 | Epithelial tube branching involved in lung morphogenesis |
| Process | GO:0060541 | Respiratory system development |
| Process | GO:0060562 | Epithelial tube morphogenesis |
| Process | GO:0060788 | Ectodermal placode formation |
| Process | GO:0060795 | Cell fate commitment involved in formation of primary germ layer |
| Process | GO:0060828 | Regulation of canonical Wnt signaling pathway |
| Process | GO:0061138 | Morphogenesis of a branching epithelium |
| Process | GO:0061458 | Reproductive system development |
| Process | GO:0065007 | Biological regulation |
| Process | GO:0065009 | Regulation of molecular function |
| Process | GO:0070848 | Response to growth factor |
| Process | GO:0070887 | Cellular response to chemical stimulus |
| Process | GO:0071241 | Cellular response to inorganic substance |
| Process | GO:0071248 | Cellular response to metal ion |
| Process | GO:0071276 | Cellular response to cadmium ion |
| Process | GO:0071696 | Ectodermal placode development |
| Process | GO:0071697 | Ectodermal placode morphogenesis |
| Process | GO:0071698 | Olfactory placode development |
| Process | GO:0071699 | Olfactory placode morphogenesis |
| Process | GO:0071704 | Organic substance metabolic process |
| Process | GO:0080090 | Regulation of primary metabolic process |
| Process | GO:0090090 | Negative regulation of canonical Wnt signaling pathway |
| Process | GO:0090596 | Sensory organ morphogenesis |
| Process | GO:0097150 | Neuronal stem cell population maintenance |
| Process | GO:0098727 | Maintenance of cell number |
| Process | GO:0150063 | Visual system development |
| Process | GO:1901700 | Response to oxygen-containing compound |
| Process | GO:1901987 | Regulation of cell cycle phase transition |
| Process | GO:1901988 | Negative regulation of cell cycle phase transition |
| Process | GO:1902531 | Regulation of intracellular signal transduction |
| Process | GO:1902533 | Positive regulation of intracellular signal transduction |
| Process | GO:1902679 | Negative regulation of RNA biosynthetic process |
| Process | GO:1902680 | Positive regulation of RNA biosynthetic process |
| Process | GO:1902692 | Regulation of neuroblast proliferation |
| Process | GO:1902806 | Regulation of cell cycle G1/S phase transition |
| Process | GO:1902807 | Negative regulation of cell cycle G1/S phase transition |
| Process | GO:1903506 | Regulation of nucleic acid-templated transcription |
| Process | GO:1903507 | Negative regulation of nucleic acid-templated transcription |
| Process | GO:1903508 | Positive regulation of nucleic acid-templated transcription |
| Process | GO:2000026 | Regulation of multicellular organismal development |
| Process | GO:2000116 | Regulation of cysteine-type endopeptidase activity |
| Process | GO:2000177 | Regulation of neural precursor cell proliferation |
| Process | GO:2000179 | Positive regulation of neural precursor cell proliferation |
| Process | GO:2001141 | Regulation of RNA biosynthetic process |
| Component | GO:0000785 | Chromatin |
| Component | GO:0005622 | Intracellular anatomical structure |
| Component | GO:0005634 | Nucleus |
| Component | GO:0005654 | Nucleoplasm |
| Component | GO:0005667 | Transcription regulator complex |
| Component | GO:0005694 | Chromosome |
| Component | GO:0005737 | Cytoplasm |
| Component | GO:0005829 | Cytosol |
| Component | GO:0031974 | Membrane-enclosed lumen |
| Component | GO:0031981 | Nuclear lumen |
| Component | GO:0032991 | Protein-containing complex |
| Component | GO:0043226 | Organelle |
| Component | GO:0043227 | Membrane-bounded organelle |
| Component | GO:0043228 | Non-membrane-bounded organelle |
| Component | GO:0043229 | Intracellular organelle |
| Component | GO:0043231 | Intracellular membrane-bounded organelle |
| Component | GO:0043232 | Intracellular non-membrane-bounded organelle |
| Component | GO:0043233 | Organelle lumen |
| Component | GO:0070013 | Intracellular organelle lumen |
| Component | GO:0110165 | Cellular anatomical entity |
| Function | GO:0000976 | Transcription cis-regulatory region binding |
| Function | GO:0000977 | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
| Function | GO:0000978 | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| Function | GO:0000981 | DNA-binding transcription factor activity, RNA polymerase II-specific |
| Function | GO:0000987 | Cis-regulatory region sequence-specific DNA binding |
| Function | GO:0001067 | Transcription regulatory region nucleic acid binding |
| Function | GO:0001216 | DNA-binding transcription activator activity |
| Function | GO:0001228 | DNA-binding transcription activator activity, RNA polymerase II-specific |
| Function | GO:0003676 | Nucleic acid binding |
| Function | GO:0003677 | DNA binding |
| Function | GO:0003682 | Chromatin binding |
| Function | GO:0003690 | Double-stranded DNA binding |
| Function | GO:0003700 | DNA-binding transcription factor activity |
| Function | GO:0003723 | RNA binding |
| Function | GO:0005488 | Binding |
| Function | GO:0005515 | Protein binding |
| Function | GO:0008134 | Transcription factor binding |
| Function | GO:0031490 | Chromatin DNA binding |
| Function | GO:0035198 | miRNA binding |
| Function | GO:0043565 | Sequence-specific DNA binding |
| Function | GO:0061629 | RNA polymerase II-specific DNA-binding transcription factor binding |
| Function | GO:0061980 | Regulatory RNA binding |
| Function | GO:0097159 | Organic cyclic compound binding |
| Function | GO:0140110 | Transcription regulator activity |
| Function | GO:0140297 | DNA-binding transcription factor binding |
| Function | GO:1901363 | Heterocyclic compound binding |
| Function | GO:1990837 | Sequence-specific double-stranded DNA binding |
Pathway annotation
| Category | Term ID | Term description |
|---|---|---|
| RCTM | RNO-162582 | Signal Transduction |
| RCTM | RNO-195721 | Signaling by WNT |
| RCTM | RNO-201681 | TCF dependent signaling in response to WNT |
| RCTM | RNO-3769402 | Deactivation of the beta-catenin transactivating complex |
| WikiPathways | WP1288 | Wnt signaling pathway and pluripotency |
| KEGG | rno04390 | Hippo signaling pathway |
| KEGG | rno04550 | Signaling pathways regulating pluripotency of stem cells |
Expression profile of Sox2 in omics data
| ID | GSE100499 |
| Title | Exploring acupuncture mechanism in preconditioning of IRI |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM2685201 | MX1 | tissue: Myocardium gender: male | 4.8142099 |
| GSM2685202 | MX2 | tissue: Myocardium gender: female | 4.8854921000000004 |
| GSM2685203 | MX3 | tissue: Myocardium gender: female | 5.13538035 |
| GSM2685204 | MX4 | tissue: Myocardium gender: male | 4.773555849999999 |
| GSM2685205 | DZ1 | tissue: Myocardium gender: male | 4.9908438 |
| GSM2685206 | DZ2 | tissue: Myocardium gender: male | 5.42107615 |
| GSM2685207 | DZ3 | tissue: Myocardium gender: female | 5.0897835 |
| GSM2685208 | DZ4 | tissue: Myocardium gender: female | 5.3540837 |
| GSM2685209 | JJ1 | tissue: Myocardium gender: male | 4.43464225 |
| GSM2685210 | JJ2 | tissue: Myocardium gender: female | 4.9212996 |
| GSM2685211 | JJ3 | tissue: Myocardium gender: female | 5.12283575 |
| GSM2685212 | JJ4 | tissue: Myocardium gender: male | 4.95887235 |
| GSM2685213 | NG1 | tissue: Myocardium gender: male | 5.184064 |
| GSM2685214 | NG2 | tissue: Myocardium gender: female | 4.48541715 |
| GSM2685215 | NG3 | tissue: Myocardium gender: male | 5.0823549 |
| GSM2685216 | NG4 | tissue: Myocardium gender: female | 4.8994044 |
| GSM2685217 | YL1 | tissue: Myocardium gender: male | 4.6945445 |
| GSM2685218 | YL2 | tissue: Myocardium gender: male | 4.5875354 |
| GSM2685219 | YL3 | tissue: Myocardium gender: female | 4.725657 |
| GSM2685220 | YL4 | tissue: Myocardium gender: female | 5.0253403500000005 |
| GSM2685221 | QC1 | tissue: Myocardium gender: male | 4.9388000000000005 |
| GSM2685222 | QC2 | tissue: Myocardium gender: male | 4.432205 |
| GSM2685223 | QC3 | tissue: Myocardium gender: female | 4.8382776 |
| GSM2685224 | QC4 | tissue: Myocardium gender: female | 4.960922249999999 |
| ID | GSE136833 |
| Title | Effects of lidocaine on the expression of rat spinal cord |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4058984 | Control_1 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 6.461429773 |
| GSM4058985 | Control_2 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 6.481943544 |
| GSM4058986 | Control_3 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 6.546290276 |
| GSM4058987 | Lidocaine_1 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 6.487822181 |
| GSM4058988 | Lidocaine_2 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 6.543036702 |
| GSM4058989 | Lidocaine_3 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 6.616895476 |
| ID | GSE138454 |
| Title | Impact of inflammation on hepatic subcellular energetics in anesthetized rats |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4108997 | Sample 1 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 0.0 |
| GSM4108998 | Sample 2 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 1.0 |
| GSM4108999 | Sample 3 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 1.0 |
| GSM4109000 | Sample 4 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 0.0 |
| GSM4109001 | Sample 5 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 0.0 |
| GSM4109002 | Sample 6 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 0.0 |
| GSM4109003 | Sample 7 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 0.0 |
| GSM4109004 | Sample 8 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 0.0 |
| GSM4109005 | Sample9 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 0.0 |
| GSM4109006 | Sample10 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 17.0 |
| GSM4109007 | Sample11 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 0.0 |
| GSM4109008 | Sample12 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 1.0 |
| GSM4109009 | Sample13 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 0.0 |
| GSM4109010 | Sample14 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 0.0 |
| GSM4109011 | Sample 15 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 0.0 |
| GSM4109012 | Sample16 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 0.0 |
| ID | GSE139220 |
| Title | Expression data from sevoflurane anesthesia treated rat |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4134285 | Brain_Control_rep1 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 8.1995 |
| GSM4134286 | Brain_Control_rep2 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 8.110165 |
| GSM4134287 | Brain_Control_rep3 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 8.234019 |
| GSM4134288 | Brain_Sevoflurane_rep1 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 8.07089 |
| GSM4134289 | Brain_Sevoflurane_rep2 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 8.042016 |
| GSM4134290 | Brain_Sevoflurane_rep3 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 7.887729 |
| ID | GSE143895 |
| Title | GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4276356 | dhsc01 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 35.519 |
| GSM4276357 | dhsc03 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 28.118 |
| GSM4276358 | dhsc05 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 31.404 |
| GSM4276359 | dhsc13 | strain: Sprague Dawley tissue: DHSC treatment: SHAM | 31.9 |
| GSM4276360 | dhsc15 | strain: Sprague Dawley tissue: DHSC treatment: SHAM | 27.386 |
| ID | GSE157924 |
| Title | Regulation of acupuncture on genes in brain stem |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4780973 | Rattus_JSSZ(Sham) | tissue: Rattus brainstem of modeling treatment: Sham | 8.194973571333334 |
| GSM4780974 | Rattus_JXZ(Hand Acu) | tissue: Rattus brainstem of modeling treatment: Hand Acu | 8.130725266 |
| GSM4780975 | Rattus_MXZ(TBI) | tissue: Rattus brainstem of modeling treatment: TBI | 8.265523465 |
| ID | GSE1779 |
| Title | Effect of Isoflurane and LTM on basolateral amygdala |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM30790 | baseline control 01 | male, 275-300g | 150.9 |
| GSM30791 | baseline control 02 | male, 275-300g | 257.2 |
| GSM30792 | baseline control 03 | male, 275-300g | 198.6 |
| GSM30793 | baseline control 04 | male, 275-300g | 118.6 |
| GSM30794 | baseline control 05 | male, 275-300g | 112.9 |
| GSM30795 | baseline control 06 | male, 275-300g | 57.4 |
| GSM30796 | baseline control 07 | male, 275-300g | 91.5 |
| GSM30797 | baseline control 08 | male, 275-300g | 133.4 |
| GSM30798 | baseline control 09 | male, 275-300g | 108.4 |
| GSM30799 | pain 01 | 209.7 | |
| GSM30800 | pain 02 | 268.3 | |
| GSM30801 | pain 03 | 190.5 | |
| GSM30802 | pain 04 | 145.4 | |
| GSM30803 | pain 05 | 277.9 | |
| GSM30804 | FC 01 | 144.1 | |
| GSM30805 | FC 02 | 274.3 | |
| GSM30806 | FC 03 | 222.2 | |
| GSM30807 | FC 04 | 173.3 | |
| GSM30808 | FC 05 | 147.0 | |
| GSM30809 | IFC 01 | 233.8 | |
| GSM30810 | IFC 02 | 125.6 | |
| GSM30811 | IFC 03 | 68.8 | |
| GSM30812 | IFC 04 | 135.6 | |
| GSM30813 | IFC 05 | 168.6 | |
| GSM99800 | isoflurane 01 | male, 275-300g | 202.1 |
| GSM99801 | isoflurane 02 | male, 275-300g | 95.6 |
| GSM99802 | isoflurane 03 | male, 275-300g | 145.5 |
| GSM99803 | isoflurane 04 | male, 275-300g | 159.6 |
| GSM99804 | isoflurane 05 | male, 275-300g | 177.8 |
| ID | GSE190472 |
| Title | Study on VEGF regulation mechanism of acupuncture improving endometrial receptivity in IVF-ET |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5724271 | model 21 | Sex: female tissue: Uterine tissue condition: model | 9.461566666666668 |
| GSM5724272 | model 22 | Sex: female tissue: Uterine tissue condition: model | 7.741133333333333 |
| GSM5724273 | model 23 | Sex: female tissue: Uterine tissue condition: model | 7.7808 |
| GSM5724274 | treatment31 | Sex: female tissue: Uterine tissue condition: treatment | 9.027366666666667 |
| GSM5724275 | treatment32 | Sex: female tissue: Uterine tissue condition: treatment | 9.474566666666666 |
| GSM5724276 | treatment33 | Sex: female tissue: Uterine tissue condition: treatment | 8.1738 |
| GSM5724277 | control 41 | Sex: female tissue: Uterine tissue condition: control | 10.0594 |
| GSM5724278 | control 42 | Sex: female tissue: Uterine tissue condition: control | 9.221133333333333 |
| GSM5724279 | control 43 | Sex: female tissue: Uterine tissue condition: control | 7.957066666666667 |
| ID | GSE192399 |
| Title | Gene expression of brain regions activated by sevoflurane and propofol |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5746332 | LHb, Sevoflurane, 60mins | brain region: the lateral habenula (LHb) treatment: Sevoflurane | 12.1111 |
| GSM5746333 | LHb, O2, 60mins | brain region: the lateral habenula (LHb) treatment: O2 | 12.3529 |
| GSM5746334 | MHb, Sevoflurane, 60mins | brain region: the medial habenula (MHb) treatment: Sevoflurane | 11.9568 |
| GSM5746335 | MHb, O2, 60mins | brain region: the medial habenula (MHb) treatment: O2 | 12.2136 |
| GSM5746336 | Sol, Sevoflurane, 60mins | brain region: the solitary nucleus (Sol) treatment: Sevoflurane | 13.8999 |
| GSM5746337 | Sol, O2, 60mins | brain region: the solitary nucleus (Sol) treatment: O2 | 14.0938 |
| GSM5746338 | Mve, Sevoflurane, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane | 11.9589 |
| GSM5746339 | Mve, O2, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: O2 | 12.2399 |
| GSM5746340 | LHb, Propofol, 60mins | brain region: the lateral habenula (LHb) treatment: Propofol | 12.837 |
| GSM5746341 | LHb, Intralipos, 60mins | brain region: the lateral habenula (LHb) treatment: Intralipos | 12.4643 |
| GSM5746342 | MHb, Propofol, 60mins | brain region: the medial habenula (MHb) treatment: Propofol | 12.4479 |
| GSM5746343 | MHb, Intralipos, 60mins | brain region: the medial habenula (MHb) treatment: Intralipos | 12.5389 |
| GSM5746344 | Sol, Propofol, 60mins | brain region: the solitary nucleus (Sol) treatment: Propofol | 13.7713 |
| GSM5746345 | Sol, Intralipos, 60mins | brain region: the solitary nucleus (Sol) treatment: Intralipos | 13.829 |
| GSM5746346 | MVe, Propofol, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Propofol | 11.7023 |
| GSM5746347 | MVe, Intralipos, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Intralipos | 11.4241 |
| ID | GSE205202 |
| Title | Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [rat] |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM6208507 | Rat_Baseline_0h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 | 4.745822 |
| GSM6208508 | Rat_Baseline_0h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 | 4.895955 |
| GSM6208509 | Rat_Baseline_0h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 | 4.819982 |
| GSM6208510 | Rat_Baseline_0h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 | 4.839444 |
| GSM6208511 | Rat_Baseline_0h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 | 4.865147 |
| GSM6208512 | Rat_Vehicle_03h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 4.817985 |
| GSM6208513 | Rat_Vehicle_03h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 4.837793 |
| GSM6208514 | Rat_Vehicle_03h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 4.89699 |
| GSM6208515 | Rat_Vehicle_03h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 4.90486 |
| GSM6208516 | Rat_Vehicle_03h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 4.740584 |
| GSM6208517 | Rat_Vehicle_06h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 4.86567 |
| GSM6208518 | Rat_Vehicle_06h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 4.811119 |
| GSM6208519 | Rat_Vehicle_06h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 4.82714 |
| GSM6208520 | Rat_Vehicle_06h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 4.868228 |
| GSM6208521 | Rat_Vehicle_06h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 4.797326 |
| GSM6208522 | Rat_Vehicle_09h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 4.89594 |
| GSM6208523 | Rat_Vehicle_09h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 4.731827 |
| GSM6208524 | Rat_Vehicle_09h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 4.932292 |
| GSM6208525 | Rat_Vehicle_09h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 4.862713 |
| GSM6208526 | Rat_Vehicle_09h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 4.810395 |
| GSM6208527 | Rat_Vehicle_24h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 4.676178 |
| GSM6208528 | Rat_Vehicle_24h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 4.816128 |
| GSM6208529 | Rat_Vehicle_24h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 4.806886 |
| GSM6208530 | Rat_Vehicle_24h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 4.788573 |
| GSM6208531 | Rat_Vehicle_24h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 4.804526 |
| GSM6208532 | Rat_APAP_03h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 4.817034 |
| GSM6208533 | Rat_APAP_03h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 4.881727 |
| GSM6208534 | Rat_APAP_03h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 4.775743 |
| GSM6208535 | Rat_APAP_03h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 4.841935 |
| GSM6208536 | Rat_APAP_03h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 4.853992 |
| GSM6208537 | Rat_APAP_06h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 4.754093 |
| GSM6208538 | Rat_APAP_06h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 4.825493 |
| GSM6208539 | Rat_APAP_06h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 4.929647 |
| GSM6208540 | Rat_APAP_06h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 4.768429 |
| GSM6208541 | Rat_APAP_06h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 4.882054 |
| GSM6208542 | Rat_APAP_09h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 4.872562 |
| GSM6208543 | Rat_APAP_09h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 4.830845 |
| GSM6208544 | Rat_APAP_09h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 4.684707 |
| GSM6208545 | Rat_APAP_09h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 4.76867 |
| GSM6208546 | Rat_APAP_09h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 4.765454 |
| GSM6208547 | Rat_APAP_24h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 4.973561 |
| GSM6208548 | Rat_APAP_24h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 4.876963 |
| GSM6208549 | Rat_APAP_24h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 4.783641 |
| GSM6208550 | Rat_APAP_24h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 4.714872 |
| GSM6208551 | Rat_APAP_24h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 4.891397 |
| ID | GSE232804 |
| Title | EGR3 regulates opioid-related nociception and motivation in male rats |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM7383519 | ww01_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 290.0 |
| GSM7383520 | ww02_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 257.0 |
| GSM7383521 | ww03_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 264.0 |
| GSM7383522 | ww05_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 313.0 |
| GSM7383523 | ww06_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 385.0 |
| GSM7383524 | ww07_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 254.0 |
| GSM7383525 | ww08_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 241.0 |
| GSM7383526 | ww10_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 247.0 |
| GSM7383527 | ww12_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 245.0 |
| GSM7383528 | ww13_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 355.0 |
| GSM7383529 | ww14_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 318.0 |
| GSM7383530 | ww15_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 308.0 |
| GSM7383531 | ww16_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 345.0 |
| GSM7383532 | ww17_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 280.0 |
| GSM7383533 | ww18_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 367.0 |
| GSM7383534 | ww20_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 229.0 |
| GSM7383535 | ww21_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 286.0 |
| GSM7383536 | ww22_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 282.0 |
| GSM7383537 | ww23_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 192.0 |
| GSM7383538 | ww24_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 237.0 |
| GSM7383539 | ww26_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 280.0 |
| GSM7383540 | ww27_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 408.0 |
| GSM7383541 | ww28_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 495.0 |
| GSM7383542 | ww30_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 342.0 |
| GSM7383543 | ww31_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 346.0 |
| GSM7383544 | ww32_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 226.0 |
| GSM7383545 | ww34_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 298.0 |
| GSM7383546 | ww35_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 338.0 |
| GSM7383547 | ww36_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 366.0 |
| GSM7383548 | ww37_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 343.0 |
| GSM7383549 | ww38_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 377.0 |
| GSM7383550 | www09_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 396.0 |
| GSM7383551 | www19_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 340.0 |
| GSM7383552 | www29_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 337.0 |
| GSM7383553 | www33_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 304.0 |
| GSM7383554 | www39_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 219.0 |
| ID | GSE2982 |
| Title | Effect of inhaled anesthetic to cultured cortical neurons |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM61779 | Cell Culture Exposure (control1) | Cy3 label;Cy5; | 0.010633333333333333 |
| GSM61796 | Cell Culture Exposure (control2) | Cy3; Cy5 | -0.11063333333333332 |
| GSM61797 | Cell Culture Exposure (control3) | Cy3; Cy5 | -0.10173333333333334 |
| GSM61798 | Cell Culture Exposure (1MAC Halo1) | Cy3; Cy5 | -0.08086666666666666 |
| GSM61799 | Cell Culture Exposure (1MAC Halo2) | Cy3; Cy5 | -0.04713333333333333 |
| GSM61800 | Cell Culture Exposure (1MAC Halo3) | Cy3; Cy5 | -0.023880000000000002 |
| GSM61801 | Cell Culture Exposure (3MAC Halo1) | Cy3; Cy5 | -0.11623333333333334 |
| GSM61802 | Cell Culture Exposure (3MAC Halo2) | Cy3; Cy5 | -0.11613333333333332 |
| GSM61803 | Cell Culture Exposure (3MAC Halo3) | Cy3; Cy5 | -0.18166666666666667 |
| GSM61804 | Cell Culture Exposure (3MAC ISO1) | Cy3; Cy5 | -0.12886666666666666 |
| GSM61805 | Cell Culture Exposure (3MAC ISO2) | Cy3; Cy5 | -0.164 |
| GSM61806 | Cell Culture Exposure (3MAC ISO3) | Cy3; Cy5 | -0.07323333333333333 |
| ID | GSE48025 |
| Title | Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch1) |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1165929 | RAT_NORA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 3.951610663666667 |
| GSM1165930 | RAT_NORA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 3.9707571703333335 |
| GSM1165931 | RAT_RA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 4.063365099333333 |
| GSM1165932 | RAT_RA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 3.8445685803333336 |
| GSM1165933 | RAT_NORA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 3.8920436190000003 |
| GSM1165934 | RAT_NORA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 3.9908530313333332 |
| GSM1165935 | RAT_AP_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 3.997749993 |
| GSM1165936 | RAT_AP_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 3.8456527719999998 |
| GSM1165937 | RAT_MTX_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 3.9159883706666663 |
| GSM1165938 | RAT_MTX_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 3.9628645396666666 |
| GSM1165939 | RAT_ANE_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 4.0747825959999995 |
| GSM1165940 | RAT_ANE_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 4.116972816333333 |
| GSM1165941 | RAT_PLA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 3.918200121 |
| GSM1165942 | RAT_PLA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 4.0548164600000005 |
| GSM1165943 | RAT_NORA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 3.9049633089999998 |
| GSM1165944 | RAT_NORA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 3.983492067666667 |
| GSM1165945 | RAT_AP_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 4.392943978666667 |
| GSM1165946 | RAT_AP_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 3.9030922903333334 |
| GSM1165947 | RAT_MTX_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 4.011278839333333 |
| GSM1165948 | RAT_MTX_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 4.045122043 |
| GSM1165949 | RAT_ANE_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 4.039220013333333 |
| GSM1165950 | RAT_ANE_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 3.8676952903333337 |
| GSM1165951 | RAT_PLA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 3.9671226033333333 |
| GSM1165952 | RAT_PLA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 3.9616131796666667 |
| ID | GSE53897 |
| Title | Genome-wide analysis of dorsal root ganglion (DRG) gene expression after morphine or oxycodone treatment |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1303240 | DRG RVM1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.663863 |
| GSM1303241 | DRG RVM2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.766431 |
| GSM1303242 | DRG RVM3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.278572 |
| GSM1303243 | DRG RVM7 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.80654 |
| GSM1303244 | DRG RVOx2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.627982 |
| GSM1303245 | DRG RVOx3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.25185 |
| GSM1303246 | DRG RVOx5 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.204345 |
| GSM1303247 | DRG RVOx7 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.938057 |
| GSM1303248 | DRG RVS4 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.156648 |
| GSM1303249 | DRG RVS5 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.299746 |
| GSM1303250 | DRG RVS6 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.0896 |
| GSM1303251 | DRG RVS7 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.40153 |
| GSM1303252 | DRG RSM1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.791171 |
| GSM1303253 | DRG RSM2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.792427 |
| GSM1303254 | DRG RSM4 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.307313 |
| GSM1303255 | DRG RSM5 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.724634 |
| GSM1303256 | DRG RSOx1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.523481 |
| GSM1303257 | DRG RSOx2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.174406 |
| GSM1303258 | DRG RSOx3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.62462 |
| GSM1303259 | DRG RSOx4 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.262962 |
| GSM1303260 | DRG RSS1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.252039 |
| GSM1303261 | DRG RSS2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.083458 |
| GSM1303262 | DRG RSS3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.02811 |
| GSM1303263 | DRG RSS6 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.876654 |
| ID | GSE58456 |
| Title | Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch 2) |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1693996 | Peripheral blood mononuclear cells from NORA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 4.300954038666666 |
| GSM1693997 | Peripheral blood mononuclear cells from NORA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 4.171102784666666 |
| GSM1693998 | Peripheral blood mononuclear cells from NORA before therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 34.16755357833333 |
| GSM1693999 | Peripheral blood mononuclear cells from RA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 16.131766655666667 |
| GSM1694000 | Peripheral blood mononuclear cells from RA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 3.4531558823333337 |
| GSM1694001 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 53.75715153666666 |
| GSM1694002 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 6.3745032350000015 |
| GSM1694003 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 7.051184885666667 |
| GSM1694004 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 5.059378732 |
| GSM1694005 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 13.690020714 |
| GSM1694006 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 11.807712678666666 |
| GSM1694007 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 7.183702931 |
| GSM1694008 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 17.860670741666667 |
| GSM1694009 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 17.19083259 |
| ID | GSE58460 |
| Title | Rheumatoid Arthritis Rat Model Treated with Acupuncture |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1165929 | RAT_NORA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 3.951610663666667 |
| GSM1165930 | RAT_NORA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 3.9707571703333335 |
| GSM1165931 | RAT_RA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 4.063365099333333 |
| GSM1165932 | RAT_RA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 3.8445685803333336 |
| GSM1165933 | RAT_NORA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 3.8920436190000003 |
| GSM1165934 | RAT_NORA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 3.9908530313333332 |
| GSM1165935 | RAT_AP_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 3.997749993 |
| GSM1165936 | RAT_AP_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 3.8456527719999998 |
| GSM1165937 | RAT_MTX_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 3.9159883706666663 |
| GSM1165938 | RAT_MTX_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 3.9628645396666666 |
| GSM1165939 | RAT_ANE_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 4.0747825959999995 |
| GSM1165940 | RAT_ANE_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 4.116972816333333 |
| GSM1165941 | RAT_PLA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 3.918200121 |
| GSM1165942 | RAT_PLA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 4.0548164600000005 |
| GSM1165943 | RAT_NORA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 3.9049633089999998 |
| GSM1165944 | RAT_NORA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 3.983492067666667 |
| GSM1165945 | RAT_AP_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 4.392943978666667 |
| GSM1165946 | RAT_AP_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 3.9030922903333334 |
| GSM1165947 | RAT_MTX_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 4.011278839333333 |
| GSM1165948 | RAT_MTX_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 4.045122043 |
| GSM1165949 | RAT_ANE_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 4.039220013333333 |
| GSM1165950 | RAT_ANE_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 3.8676952903333337 |
| GSM1165951 | RAT_PLA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 3.9671226033333333 |
| GSM1165952 | RAT_PLA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 3.9616131796666667 |
| GSM1412003 | RAT_NORA_T0_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412004 | RAT_NORA_T0_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412005 | RAT_RA_T0_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412006 | RAT_RA_T0_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412007 | RAT_NORA_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412008 | RAT_NORA_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412009 | RAT_AP_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412010 | RAT_AP_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412011 | RAT_MTX_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412012 | RAT_MTX_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412013 | RAT_ANE_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412014 | RAT_ANE_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412015 | RAT_PLA_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412016 | RAT_PLA_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412017 | RAT_NORA_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412018 | RAT_NORA_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412019 | RAT_AP_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412020 | RAT_AP_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412021 | RAT_MTX_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412022 | RAT_MTX_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412023 | RAT_ANE_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412024 | RAT_ANE_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412025 | RAT_PLA_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412026 | RAT_PLA_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412027 | RAT_RA_T0_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412028 | RAT_RA_T0_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412029 | RAT_AP_1h_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412030 | RAT_AP_1h_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412031 | RAT_PLA_1h_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412032 | RAT_PLA_1h_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412033 | RAT_AP_34d_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412034 | RAT_AP_34d_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412035 | RAT_PLA_34d_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412036 | RAT_PLA_34d_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1693996 | Peripheral blood mononuclear cells from NORA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therap | 4.300954038666666 |
| GSM1693997 | Peripheral blood mononuclear cells from NORA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 4.171102784666666 |
| GSM1693998 | Peripheral blood mononuclear cells from NORA before therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 34.16755357833333 |
| GSM1693999 | Peripheral blood mononuclear cells from RA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 16.131766655666667 |
| GSM1694000 | Peripheral blood mononuclear cells from RA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 3.4531558823333337 |
| GSM1694001 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 53.75715153666666 |
| GSM1694002 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therap | 6.3745032350000015 |
| GSM1694003 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 7.051184885666667 |
| GSM1694004 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 5.059378732 |
| GSM1694005 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 13.690020714 |
| GSM1694006 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 11.807712678666666 |
| GSM1694007 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 7.183702931 |
| GSM1694008 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 17.860670741666667 |
| GSM1694009 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 17.19083259 |
| ID | GSE8911 |
| Title | Skeletal muscle after fine needle stimulation |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM225891 | Skeletal muscle sample from fine needle-stimulated hindlimb | Strain: Lewis, Gender: Male, Body Weight: 275g, Tissue: Skeletal muscle sample from fine nnedle-stimulated hindlimb | 1.2434613333333333 |
| GSM225892 | Skeletal muscle sample from control hindlimb | Strain: Lewis, Gender: Male, Body weight: 275g, Tissue: skeletal muscle sample from non fine needle-stimulated hindlimb | 4.32057 |
